Biliary Stricture Clinical Trial
Official title:
To Establish a Multicenter Registry to Evaluate the Impact of Photodynamic Therapy in the Management of Patients With Unresectable Cholangiocarcinoma.
Currently, very few centers offer Photodynamic therapy for unresectable Cholangiocarcinoma
in the United States. Several European studies have reported the efficacy and safety of
Photodynamic Therapy (PDT) for Cholangiocarcinoma, however, only a few studies have reported
the same in the United States.
The establishment of a registry to capture all PDT cases within and outside US can help the
investigators evaluate a larger and non-ambiguous sample population. This would help the
investigators evaluate the technical success rates, clinical success rates, feasibility and
safety of PDT for unresectable cholangiocarcinoma. With more endoscopists considering PDT as
a therapeutic option along with adjuvant treatment for cholangiocarcinoma, there is a need
to further evaluate the efficacy and safety of such combined procedures as well. The
ultimate objective is to assess if PDT with or without additional or adjuvant treatment
options prolongs survival duration and improves quality of life in patients with
unresectable cholangiocarcinoma.
This multicenter registry has been initiated:
- To document the impact of PDT on the clinical management of unresectable
cholangiocarcinoma.
- To assess the clinical and technical success rates of PDT for unresectable
cholangiocarcinoma.
PDT offers a number of practical advantages; it is minimally invasive and has a low
complication rate, the procedure can easily be performed by a trained endoscopist, and it is
well tolerated. In the trial conducted in Germany, the adverse events of PDT were mild to
moderate, predictable, and relatively easy to control. Photosensitivity was the only
systemic side effect (seen in only three patients). However, provided that simple guidelines
for light exposure are followed, there is minimal risk to the patient, as shown by the low
incidence of photosensitivity reactions in this study which all resolved.
A study from the Mayo group included 25 patients with unresectable cholangiocarcinoma who
were treated with PDT from 1991 to 2004 showed that the time interval between diagnosis and
treatment with PDT is an important predictor of survival following PDT even when adjusted
for other potential factors that affect survival such as age, gender, Bismuth stage,
presence of tumor mass on imaging and presence of extra biliary spread. Early treatment with
PDT may lead to greater preservation of liver function. A recent study by the primary
investigator has also recently reported improved survival in patients receiving PDT and
stent compared to stent only (16.2 months vs 7.4 months).
Several other European studies have reported the efficacy and safety of PDT for
cholangiocarcinoma; however, only a few studies have reported the same in the United States.
This is again due to the fact that PDT is not offered as a therapeutic option for
unresectable cholangiocarcinoma within US.
However, the establishment of a registry to capture all PDT cases within and outside US can
help the investigators evaluate a larger and non ambiguous sample population. This would
help the investigators evaluate the technical success rates, clinical success rates,
feasibility and safety of PDT for unresectable cholangiocarcinoma.
The involvement of international sites is crucial, as the advanced endoscopists all over the
world are offering photodynamic therapy for managing unresectable cholangiocarcinoma.
However, because of the non-existence of a registry, and the fact that PDT is not offered in
more than a few centers in the US; these cases are often reported with a smaller sample
size. The registry hopes to combine all such comparable cases and collect enough relevant
data for statistical analyses.
With more endoscopists considering PDT as a therapeutic option along with adjuvant treatment
for cholangiocarcinoma, there is a need to further evaluate the efficacy and safety of such
combined procedures as well. The ultimate objective is to assess if PDT with or without
additional or adjuvant treatment options prolongs survival duration and improves quality of
life in patients with unresectable cholangiocarcinoma.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03115411 -
Prospective Evaluation of Winged Biliary Stent Patency in Patients With Benign Biliary Obstruction
|
N/A | |
Completed |
NCT02041390 -
Effect of Short Message Service Intervention on Stent Removal/Exchange Adherence in Patients With Benign Pancreaticobiliary Diseases
|
N/A | |
Recruiting |
NCT01439698 -
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
|
N/A | |
Terminated |
NCT01413386 -
Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent
|
N/A | |
Completed |
NCT01543256 -
WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study
|
N/A | |
Enrolling by invitation |
NCT04572711 -
Prospective Evaluation of Biliary Tissue Sampling With ERCP
|
||
Recruiting |
NCT03229655 -
Evaluation of Sequential Stent Addition vs. Incremental Dilation & Stent Exchange for Management of Anastomotic Biliary Strictures After Liver Transplantation
|
N/A | |
Completed |
NCT02916199 -
Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method
|
N/A | |
Recruiting |
NCT01522573 -
T-EUS for Gastrointestinal Disorders: A Multicenter Registry
|
N/A | |
Completed |
NCT02281019 -
SpyGlass AMEA Registry
|
||
Recruiting |
NCT04010734 -
Primary Cholangioscopy Versus ERCP in the Diagnosis of Biliary Strictures
|
N/A | |
Not yet recruiting |
NCT06369896 -
Digital Single-operator Cholangioscopy and Intraductal Ultrasound for Nonicteric Biliary Strictures
|
||
Recruiting |
NCT04391153 -
FISH in Diagnosis of Biliary Stricture
|
N/A | |
Active, not recruiting |
NCT03997994 -
DIGEST I Drug Coated Balloon for Biliary Stricture
|
N/A | |
Enrolling by invitation |
NCT03951324 -
Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study
|
||
Unknown status |
NCT01085747 -
Endoscopic Treatment of Biliary Stricture Caused by Chronic Pancreatitis
|
N/A | |
Completed |
NCT02105181 -
Fully Covered Self-expandable Metal Stents (FCMS) in Benign Biliary Strictures
|
N/A | |
Recruiting |
NCT05761483 -
Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.
|
||
Completed |
NCT03673033 -
Biliary Complications in Live Donor Liver Transplantation
|
||
Recruiting |
NCT06277531 -
Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
|